相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Promising Protective Effects of Chrysin in Cardiometabolic Diseases
Marjan Talebi et al.
CURRENT DRUG TARGETS (2022)
A Comprehensive Review on Chrysin: Emphasis on Molecular Targets, Pharmacological Actions and Bio-pharmaceutical Aspects
Anuj Garg et al.
CURRENT DRUG TARGETS (2022)
Insight into the Role of the PI3K/Akt Pathway in Ischemic Injury and Post-Infarct Left Ventricular Remodeling in Normal and Diabetic Heart
Bartosz Walkowski et al.
CELLS (2022)
An inquest into regulatory mechanism of caveolin by ischemic preconditioning against orchidectomy-challenged rat heart
Ritesh Kumar Srivastav et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2021)
Chrysin attenuates high-fat-diet-induced myocardial oxidative stress via upregulating eNOS and Nrf2 target genes in rats
Subramani Yuvaraj et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2021)
Role of Heme Oxygenase-1(HO-1) and Endothelin-1 (ET-1) in Modulation of Cardioprotective Effect of lschemic Postconditioning in Diabetic Rat Heart
Richa Rohilla et al.
INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH (2020)
Chrysin ameliorates cerebral ischemia/reperfusion (I/R) injury in rats by regulating the PI3K/Akt/mTOR pathway
Teng-Fei Li et al.
NEUROCHEMISTRY INTERNATIONAL (2019)
Chrysin Pretreatment Improves Angiotensin System, cGMP Concentration in L-NAME Induced Hypertensive Rats
Ramanathan Veerappan et al.
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY (2019)
ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotection
Susana Cadenas
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Chrysin: Sources, beneficial pharmacological activities, and molecular mechanism of action
Renuka Mani et al.
PHYTOCHEMISTRY (2018)
Angiotensin (1-7) facilitates cardioprotection of ischemic preconditioning on ischemia-reperfusion-challenged rat heart
Pradeepkant Pachauri et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2017)
Ischemic preconditioning: Interruption of various disorders
Ahsas Goyal et al.
JOURNAL OF THE SAUDI HEART ASSOCIATION (2017)
Mortality and morbidity trends after the first year in survivors of acute myocardial infarction: a systematic review
Saga Johansson et al.
BMC CARDIOVASCULAR DISORDERS (2017)
Abrogated cardioprotective effect of ischemic preconditioning in ovariectomized rat heart
A. Goyal et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2016)
Chrysin treatment improves diabetes and its complications in liver, brain, and pancreas in streptozotocin-induced diabetic rats
Saeed Samarghandian et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2016)
Chrysin, a PPAR-γ agonist improves myocardial injury in diabetic rats through inhibiting AGE-RAGE mediated oxidative stress and inflammation
Neha Rani et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2016)
Ischemia reperfusion injury, ischemic conditioning and diabetes mellitus
Anne Lejay et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Role of atrial natriuretic peptide in ischemic preconditioning-induced cardioprotection in the diabetic rat heart
Kali Charan et al.
JOURNAL OF SURGICAL RESEARCH (2016)
Mushrooms do not contain flavonoids
Alicia Gil-Ramirez et al.
JOURNAL OF FUNCTIONAL FOODS (2016)
Flavonoids from the leaves of Carya cathayensis Sarg. inhibit vascular endothelial growth factor-induced angiogenesis
Sha-Sha Tian et al.
FITOTERAPIA (2014)
Evaluation of the anti-atherogenic potential of chrysin in Wistar rats
Ramalingam Anandhi et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
Derek J. Hausenloy et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
The Age-Specific Quantitative Effects of Metabolic Risk Factors on Cardiovascular Diseases and Diabetes: A Pooled Analysis
Gitanjali M. Singh et al.
PLOS ONE (2013)
Aging might increase myocardial ischemia/reperfusion-induced apoptosis in humans and rats
Miaobing Liu et al.
AGE (2012)
Is remote ischaemic preconditioning of benefit to patients undergoing cardiac surgery?
Jakub Marczak et al.
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2012)
National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants
Goodarz Danaei et al.
LANCET (2011)
Angiotensin II Type 1 Receptor-Mediated Upregulation of Calcineurin Activity Underlies Impairment of Cardioprotective Signaling in Diabetic Hearts
Hiroyuki Hotta et al.
CIRCULATION RESEARCH (2010)
Modulation of the cardioprotective effect of ischemic preconditioning in hyperlipidaemic rat heart
Harlokesh Narayan Yadav et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Involvement of GSK-3β in attenuation of the cardioprotective effect of ischemic preconditioning in diabetic rat heart
Harlokesh Narayan Yadav et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
Antioxidants in Wild Mushrooms
Isabel C. F. R. Ferreira et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase
Mahesh Thirunavukkarasu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment
Goodarz Danaei et al.
LANCET (2006)
Luteolin and chrysin differentially inhibit cyclooxygenase-2 expression and scavenge reactive oxygen species but similarly inhibit prostaglandin-E2 formation in RAW 264.7 cells
Gabriel K. Harris et al.
JOURNAL OF NUTRITION (2006)
Preconditioning the diabetic heart - The importance of Akt phosphorylation
A Tsang et al.
DIABETES (2005)
Effects of gemfibrozil treatment on vascular reactivity of streptozotocin-diabetic rat aorta
G Ozansoy et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2004)
Possible role of nitric oxide and mast cells in endotoxin-induced cardioprotection
V Parikh et al.
PHARMACOLOGICAL RESEARCH (2001)